<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 301 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page300.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=301">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 301 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 301</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=301"><img src="../thumb/301.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>264 / 2020-04                                                            Anti-Microbials - 18.12
   ordinat., hypoaesthes., rhinit., pain, hypophosphataem., bone pain,   Drug interactions: Reduc.NNRTI conc.with St John’s Wort ex-  decr., rifampicin decr. efavirenz conc., reduc.atorvastat./pravastat.&
   osteomalac., nephrit., nephrogen. diabet. insipid., ren.proxim.tubul.  pect., poss.addit.CNS effs.with alcoh. /psychoact.meds., plasma   simvastat. conc., ethinyl oestrad.conc.incr., decr. methadone plas-
   eff.incl.Fanconi syndr.& ac.tubul.necros., ac.ren.fail., sinusit., URTI,   conc.of other compds. that are CYP3A4 substrat.poss.decr., meds.   ma conc.& poss.opiate withdr. signs with efavirenz, decr.lopinavir
   nasopharangit., hypersens., immune reconstitut. syndr., Cushingoid   induc.CYP3A4 activ.incr.clear., ser.conc.of drugs elimin.by act.tu-  expos.with lopinavir/ ritonavir & efavirenz, incr.ritonavir conc. with
   appear., redistribut./accumulat. of body fat, vit.D defic., hyperglyc-  bul.secret.may incr., atazanavir conc.decr., atazanavir incr.tenofovir   efavirenz & vice versa.
   eridaem., hyperglycaem., hyperlactataem., insul.resist., breast en-  conc., amprenavir ser.conc.decr., metabol.of indinavir incr., tenofovir
   largem., periph.& fac.wast., hyperton., myosit., rhabdomyolys., oste-  conc.incr.& lopinavir conc. decr.with lopinavir /ritonavir, ritonavir &   BARACLUDE, Equity [P/S]
   onecros., reduc.bone density., gynecomast., abnorm.vis.  efavirenz conc. incr.with ritonavir, saquinavir conc. decr., didanosine   Entecavir.
   Special precautions: Monit.hepat.funct.for sev. mnths. in pts.  conc.incr., warfar.plasma conc. incr./decr., carbamazepine/pheny-  Indications: Chron.HBV infect.in adults with act.vir.replicat.& either
   co-infect.with HIV & HBV who discont. ther.& appropr.init.of anti-  toin/ phenobarbit. & efavirenz conc.decr.with these anticonvuls.,   evid.of persist.ALT or AST elev./histologic.act.dis.
   hepatit.B ther. poss.necess., obesity & prolong.nucleoside use poss.   sertraline/itraconazole/ ketoconazole/ clarithromyc./rifabutin/Ca   (S4) TABS, A40/20.2.8/0277, 0278
   risk fact.for lact.acidos., liv.dis.risk fact., discont. if clinic./lab.find.  chan.block. / HMG-CoA reduct.inhibit.& methadone plasma conc.  710258-001: 0,5 mg, 30, R2 905,46
   suggest.lact.acidos./ hepatotoxic., test for chron.hepatit.B bef.init.  decr., rifampicin decr. efavirenz conc., ethinyl oestrad.conc.incr.  710259-001: 1 mg, 30, R5 809,72
   ther., monit.for hepatit.exacerbat.if treatm.discont.in HIV & HBV co-  Dosage: Admin.on empty stomach (ie. 2 hrs. bef./aft.meal) as ab-
   infect.pts., treatm.discont.poss.reqd.if ser. psych.sympt.exper., de-  ATROIZA, Mylan [P/S]  sorpt.decr.if admin.with food.
   term.creatin.clear.bef. init. & dur.ther., ren.funct.monit.in pts.at risk/   Emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg, efa-  Nucleoside treatm.-naïve adults & adolesc. over 16 yrs:
   hist. of ren.dysfunct., avoid with concom./rec. nephrotox. agents, el-  virenz 600 mg.  0,5 mg once dly.
   derly, rash report.with efavirenz & clarithromycin theref.consid.alt.,   Indications: HIV-1 infect.treatm.in adults.  Lamivudine-refract.pts: 1 mg once dly.
   poss. incr. didanosine-relat.adverse eff., high.freq. adverse events   (S4) TABS, 45/20.2.8/0172  Contraindications: Lactat., safety in pregn.not est., safety in pts.
   with efavirenz/ritonavir, monit. liv.enzym.with efavirenz/ritonavir,   717837-001: 30, R466,97  und.16 yrs.not est.
   do not admin. concom. saquinavir as sole protease inhibit., reg.   Dosage: Adults: 1 tab.swall.whole once dly.on empty stomach.   Side effects: Lact.acidos.& sev.hepatomegaly with steatos.incl.fa-
   carbamazepine /phenyt./phenobarb.lev.monit.with concom. use,   Bedt.dos.may improv. CNS sympt. tolerabil. Regul.dos.sched.ad-  talat., headache, fatig., dizzin., naus., insomn., somnol., GI disturbs.
   altern.anticonvuls.agent advis., Ca chann. blocks.dos. adjustm.guid.  vis. If dos.miss., take miss.dos.immed.unless it is 12 hrs unt.next   Special precautions: Sev.ac.exacerbat.of hepatit.B when ther.
   by clinic.respons., women of child-bear.potent.should undergo pregn.   day’s dos. In this case skip miss.dos.& take next dos.at usual time.  discont., monit.hepat.funct. for sev.mnths.follow.anti-hepatit.B
   test.bef.init.ther., barr.contracept.tog.with other methods recomm.,   Contraindications: Sev.hepat.impairm., concom. astemizole/cisap-  ther. discontinat., resume HBV ther.if warrant., ren.impairm., safety
   pt.on treatm.may devel. opportunist. infect./other HIV infect.compl.,   ride/midazolam/triazolam/ pimozide/ bepridil/ergot alkal./St John’s   & effic.in liv.transplants. unknown however monit.ren.funct.of liv.
   contin. approp.precaut.prevent.HIV transmiss.risk, investig. child.ex-  Wort/ voriconazole , mod-sev.ren.impairm., safety in pregn. not est.,   transplant pts.receiv.immunosuppress.affect. ren. funct.if admin.,
   pos.in utero to nucleoside & nucleotide analog.for poss.mitochondr.  lactat., safety & effic.in pts.less than 18 yrs.not est., rare heredit.  no evaluat.of HIV/HBV co-infect. pts not receiv.simultaneous.effect.
   dysfunct.in case of relev.S&S, liv.enzym.monit.in pts.with mild to   probl., galact. intol. hist., Lapp lact.defic., gluc.-galact. malabsorpt.,   HIV treatm., ther. not proven to prev.transmiss., concom. meds. that
   mod.liv.dis & chron.hepatit.B or C, seiz/psych. disord. hist., discont.  chron.HBV infect., safety & effic.not est. in HBV & HIV co-infects.,   are excret.ren./aff.ren.funct.
   ther.with sev.skin rash assoc. with blister./desquamat./mucos.in-  concom.cytidine analog. such as lamivudine/adefovir dipivoxil, con-  Drug interactions: Meds.that reduc.ren. funct./ compete for act.
   volvem.& fev., monit.ser.lipids & bld.gluc., bone monit.with bone   com. meds.cont.efavirenz/emtricitabine/ tenofovir, pts.with creat.  tubul.secret.poss.incr.ser.conc. of either med.
   fract. hist./risk of osteopen.  clear.&lt;50 ml/min./ haemodyalis., concom.amprenavir/atazanavir/   BAVIR, (Activo) Aurobindo [P/S]
   Drug interactions: Reduc.NNRTI conc.with St John’s Wort expect.,   ritonavir, concom.lopinavir/ritonavir not recomm., saquinavir/rito-  Abacavir sulph.
   addit.CNS effs.with alcoh./ psychoact.meds., alt.plasma conc.of   navir not recomm., concom. didanosine not recomm.  Indications: Antiretroviral combinat.ther.for HIV treatm.in infect.
   meds.prim. metab.by cytochrome P450 isoenzym., CYP3A4 induc.  Side effects: Bld.dyscras., lactic.acidos.& sev. hepatomegaly with   adults & childr.
   decr. efavirenz conc., clarithromyc.plasma lev. decr., efavirenz decr.  steatos.somet.fatal esp. women, hypertriglyceridaem., hypergly-  (S4) TABS, 41/20.2.8/0917
   voriconazole plasma conc. & voriconazole incr.efavirenz plasma   caem., headache, asthen., neurit., paraesthes., periph. neuropathy,   720837-001 300 mg, 60, R1 066,13
   conc., amprenavir./fosamprenavir/atazanavir/indinavir/ lopinavir   dizzin., psych.disords.incl.psychos.-like reacts/ sev.ac.depress.incl.  (S4) ORAL SOL., 41/20.2.8/0387
   & saquinavir ser.conc decr., efavirenz metabol.inhibit.by grape-  suic.attempts/ideat., incr. cough/sweat., rhinit., GI disturbs.incl.   720838-001 20 mg/ml, 240 ml, R399,46
   fruit juice, drugs reduc. ren. funct./compete for elimin.by act.tubul.  malabsorpt. /gastro-oesophag.refl., rais.liv. enzym., hyperbilirubi-  Dosage: For use by physic.exper.in HIV managem.
   secret. may incr.ser.conc.of emtricitabine/tenofovir &/ other ren.  naem., skin reacts.incl. vesiculobull. rash/ Stev. Johns.syndr./acne,   Adults & adolesc.over 12 yrs: Recomm.dos: One 300 mg tab.
   elimin.meds, atazanavir & lopinavir/ ritonavir incr.tenofovir conc.,   skin discolour. manif.by hyperpigmentat.on palms &/ soles, arthralg.,   or 15 ml oral sol.2xdly.
   reduc.anticonvuls.& /efavirenz.plasma lev.with carbamazepine/   myalg., haematur., allerg.reacts., hyperphosphataem., chest/ back/  Childr.3 mnths-12 yrs: Recomm.dos: 8 mg/kg 2xdly up to
   phenytoin & phenobarbit., sertraline conc.decr., HMG-CoA reduct.  abdom.pain, pneum., dyspn., pancreatit., incr. creatin. lev., nephrit.,   max.600 mg dly.
   inhibit./indinavir/itraconazole conc.decr., potent.decr.ketoconazole   nephrogen.diab.insipid., ren.impairm.incl. ac. ren.fail., ren.proxim.  Contraindications: Hepat.impairm., pregn.& lactat., childr.
   conc., rifampicin decr.efavirenz conc., rifabutin conc. decr., plasma   tubul.eff.incl.Fanconi syndr., ac.tubul.necros., fev., sweat., weight/   und.3 mnths.
   conc.of other compds.that are CYP3A4 substrat.poss.decr., poss.Ca   libido chang., ser.CNS/psych.effs., hypoaesthes., abnorm. co-ordi-  Side effects: Lact.acidos.& sev.hepatomegaly with steatos., hy-
   chan.block. conc.decr., decr.methadone plasma conc.& poss. opiate   nat., atax., convuls., paraesthes., trem., impot., neuralg., vertigo,   persens.react.somet.fatal with foll. sympt: lymphopen., paraes-
   withdr.signs with efavirenz, ethinyl oestrad. conc.incr., plasma conc.  speech disord., abnorm. vis., tinnit., flush., palpitat., tachycard.,   thes., headache, dyspn., sore throat, cough, osteonecros., body
   of warfar.potent.incr./ decr.  asthma, sinusit., URTI, alopec., fatig., alcoh.intol., flu-like sympt.,   fat redistrib./ accumul., GI disords., hepat.fail., elev. LFT, rash, ren.
   ATRIPLA, MSD, [P/S]          malaise, syncope, body fat redistribut./ accumulat., hepatit., rais.  fail., hypersens.sympts.worsen.with cont. ther., fatig., fev., malaise,
   Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-  liv.enzym./ triglycer./ cholestr., hepat.fail., immune reconstitut. syndr.  oed., lymphadenopathy, hypotens., conjunctivit., anaphylax., elev.
   marate 300 mg.               Special precautions: Reproduct.toxic.incl. teratogen. effs. with   bld.gluc./triglycerid., diarrh., skin reacts. incl.Stev.Johns.syndr./
                                studies of efavirenz in animals, barrier contracept.tog.with other
   Indications: Alone as complete regimen or in combinat.with other   erythema multiforme/ tox.epiderm.necrolys., lethargy, pancreatit.,
   antiretrovir.in adults with HIV-1.  methods advis. for 12 wks.aft.discont.ther., women of child-bear.   mitochondr.damage
   (S4) TABS, 42/20.2.8/0729    potent.to undergo pregn.test.bef.init.ther., efavirenz & tenofovir ex-  Warnings and special precautions: Hypersens. reacts. charact.
   715578-001: 30, R747,93      cret.in milk of rats, ther. init. by physic. exper.in HIV infect.managem.,   by multi-organ/body syst.involvem. have proven fatal, sympt.usuall.
   Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may   elderly esp.&gt;65 yrs., concom.rifampicin, test for hepatit. B bef.init.  appear with.1 st  6 wks.of ther., discont.ther.if hypersens.react. devel.&
   improv.CNS sympt. tolerabil.  ther., monit.pts.co-infect.with HIV/ HBV for exacerbat.of hepatit.B   not to be re-challeng., opportunist.infects. & other HIV complicat.may
   Contraindications: Concom.astemizole/ bepridil/ cisapride/mi-  aft.treatm. discont., separ.preps.avail.if treatm.discont./dos. mod-  still devel., advis.pt. that antiretrovir.ther.not been prov.to prev. trans-
   dazolam/pimozide/ triazolam or ergot derivat., concom.voricona-  ific. of Atroiza compon.indicat.& refer to P/I, consid. efavirenz long   miss. through sex.cont./bld.contam.& appropr. precaut.to contin., im-
   zole, mod-sev.ren.impairm., safety & effic.not est.in hepatit. B vir.  half-life & long emtricitabine & tenofovir intracell.half-liv.if treatm.   mune reconstit.s yndr., seek medic.advice in joint aches & pains/
   co-infects., concom.meds/combinat. contain lamivudine, safety &   discont., discont.ther.in case of sev.rash assoc. with blist./desqua-  joint stiffn/diffic.in movement due to osteonecros. risk, clinic.exam.
   effic.in pts.less than 18 yrs.not est., pregn.& lactat.  mat./mucos.involvem./ fev., treatm.discont.poss.reqd.if ser.psych.  to incl.evaluat.for phys.signs of lipodystrophy., with evid.of lipodystr.
   Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.fa-  sympt. exper., liv.enzym.monit.in pts.with known/susp. Hepatit. B   do a CV risk assessm., liv.disords./dis, known liv.dis.risk fact., susp.
   tal., sev.ac.exacerbat.of hepatit B aft.discontinuat., ser.psych.sympts.  or C or treat.with meds.assoc.with hepat. toxic., pt.on treatm.may   treatm.if clinic./lab.find.suggest.of lact. acidos./ hepatotoxic.devel.,
   incl. sev. depress./suicid.ideat./non fatal suicide attempts/ aggress.  devel.opportunist. infect./ other HIV infect.compl., contin.approp pre-  incr.in malign.& non-malign. tumours in lab.anim., potent.clinic.be-
   behav./agitat./anx./paranoid & manic reacts., CNS sympts.incl.hallu-  caut. prevent.HIV transmiss.risk, monit.BMD in pts. with patholog.  nef. outweighs carcinogen.risk., consid.pancreatit.in pts. develop.
   cinat./ abnorm. think.& depersonalisat.which gen. improv. with cont.  bone fract.hist./at risk of osteopen., Ca & vit.D supplementat.poss.  abdom.pain/N&V/elev.biochemic. marks. & discont.until diagnos.of
   ther., ren.impairm.incl.ac.ren. fail., skin rash, pain, asthen., GI disturbs.,   benef., obesity/ prolong.nucleoside expos.risk, known liv. dis. risk   pancreatit.excl., incr.risk of sev./potent.fatal hepat.adverse react.in
   pancreatit., arthralg., incr.cough, fev., myalg., hypoaesthes., periph.   fact., discont.if find.suggest.lact. acidos./ hepatotoxic., avoid with   chron. hepatit.B/C pts.treat.with anti-retrovir.ther., ref. to prod.lit.of
   neuropathy, periph.neurit., pneumon., rhinit., hyperpigmentat.of palms   concom./rec.nephrotox. agents, monit.hepat.funct.for sev.mnths.in   concom.antivir.ther.for hepatit. B/C, monit. pts.co-infect.with HIV &
   &/ soles, fatig., URTI, incr.lipid conc., palpitat., tinnit., gynaecomast.,   pts.co-infect. with HIV & HBV who discont.ther.& appropr. init.of   HBV closely on discont.ther., heredit.fruct.intol.
   abnorm.vis., GI malabsorpt., hepatobil.disords., incr.hepat. enzymes,   anti-hepatit.B ther.poss.necess., monit. triglycer./cholestr.lev., con-  Drug interactions: Metabol.alter.by concom. ethanol, C max reduc./
   allerg.reacts., body fat redistribut./ accumulat., myopathy, abnorm.co-  com.grapefr. juice, monit. in case of hepat.impairm., per. anticonvuls.   one hr.delay in t max with methadone, poss.interact.with retinoid
   ordinat., atax., convuls., hypoaesthes., trem., dyspn., flush., erythema   plasma monit.if substr.of CYP450 isoenzym., per. carbamazepine   compds.but not stud.
   multiforme, Stev.-John.syndr., nail disords., photoallerg.dermatit.,   lev.monit.with concom. use, no dos.recomm.for itraconazole avail.   BETA-VIRA, (Unicorn) AI Pharm Ltd. [P/S]
   osteomalac., lumb. spine/ hip BMD decr.from baseline, convuls., in-  theref.seek.alt. antifung., do not admin.concom. saquinavir as sole   Acyclovir
   flamm.respons.to indolent/resid. infects. necessit.furth.eval.& treatm.  protease inhibit., consid. clarithromycin alt., monit.cholest.lev.with   Indications: Lip applic.in early treatm.of recurr. H.simpl. infects.
   Special precautions: Monit.hepat.funct.for sev. mnths.in pts.co-  atorvastatin/ pravastatin/ simvastatin, monit. withdr. signs with   (S1) CREAM. 31/20.2.8/0549. 0,05 g/g,
   infect.with HIV & HBV, obesity & prolong.nucleoside use poss.risk   methadone, monit.liv.enzyme with concom.ritonavir, cons.alt.anti-  713942-001: 2 g, R25,22
   fact. for lact.acidos., liv.dis.risk fact., discont.if find. suggest. lact.aci-  convuls.to carbamazepine.  Dosage: Adults & childr: Init.as soon as poss. esp. recurr.episod.
   dos./hepatotoxic., test for chron. hepatit. B bef.init.ther., immed.risk   Drug interactions: Reduc.efavirenz conc.with St John’s Wort ex-  dur.prodrom.per./when les.first appear. Apply 5-6x/day 3-4 hrly
   vs.benefit eval. of cont.ther.when ser.psych.sympts.exper., determ.   pect., plasma conc.of other compds. that are CYP3A4 substrat.poss.  x5-10 days.
   creatin.clear.bef.init.ther., avoid with concom./ rec.nephrotox.agents,   decr., efavirenz decr .voriconazole plasma conc.& vice versa, conc.of   Contraindication: Safety in pregn.& lactat.not est.
                 st
   poss.foet.harm. when admin.dur.1  trimest.theref.avoid pregn., barr.   drugs elimin.by act.tubul.secret. may incr., poss.incr.conc.of emtricit-  Side effects: Trans.burn./sting., erythem., mild dryn.& skin flak.
   contracept.tog.with other methods recomm., elderly, concom.didano-  abine /tenofovir &/ other renal.elimin.meds with meds. reduc. ren.  Special precautions: Not recomm.for mucous membr.applic.
   sine/atazanavir /lopinavir/ritonavir & discont.if advers.effs. develop,,   funct./compete for act.tubul.secret., amprenavir ser.conc decr., ataza-
   do not admin.concom.saquinavir as sole protease inhibit., no dos.  navir/ritonavir incr.tenofovir conc., decr.indinavir conc.with efavirenz,   CELSENTRI, GSK
   recomm.for itraconazole avail. theref.seek alt.antifung., rash report.   incr.tenofovir conc.with lopinavir/ ritonavir, sequinavir conc.reduc.,   Maraviroc
   with efavirenz & clarithromycin theref. consid. alt.eg. azithromycin,   reduc./incr. plasma lev.of phenytoin/phenobarb./other anticonvuls   Indications: In combinat.with other antiretrovir. meds.for treatm.-
   combinat.with other macrolides not stud., monit.BMD in pts.with   which are substrat.of CYP450 isoenzym., decr.carbamazepine lev.,   exper.adult pts.infect.with only CCR5-tropic HIV-1 detectable who
   patholog. bone fract. hist./at risk of osteopen., Ca & vit.D supplemen-  itraconazole/ sertraline conc.decr., poss.Ca chan.block.conc. decr.,   have evid.of vir.replicat.& HIV-1 strains resist.to multipl. antiret-
   tat. poss benefic., seiz.hist., period. plasma monit.of anticonvuls.ther.  reduc.diltiazem conc., clarithromyc.plasma lev. chang., rifabutin conc.  rovir. agents.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page300.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page296.html">296</a>&nbsp;&nbsp;&nbsp;<a href="page297.html">297</a>&nbsp;&nbsp;&nbsp;<a href="page298.html">298</a>&nbsp;&nbsp;&nbsp;<a href="page299.html">299</a>&nbsp;&nbsp;&nbsp;<a href="page300.html">300</a>&nbsp;&nbsp;&nbsp;<a href="page301.html">301</a>&nbsp;&nbsp;&nbsp;<a href="page302.html">302</a>&nbsp;&nbsp;&nbsp;<a href="page303.html">303</a>&nbsp;&nbsp;&nbsp;<a href="page304.html">304</a>&nbsp;&nbsp;&nbsp;<a href="page305.html">305</a>&nbsp;&nbsp;&nbsp;<a href="page306.html">306</a>
             </td>
             <td width="35%"><a href="page302.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page302.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
